Comments
Commented by Nico Popp on July 3rd, 2025 | 07:00 CEST
Unparalleled expertise in tungsten: Why Almonty Industries is in pole position
For around ten years, Almonty Industries has been synonymous with tungsten sourced from geopolitically stable regions. In just a few weeks, the massive Sangdong mine in South Korea will go into production, making the world significantly less dependent on tungsten from China. The market is rewarding this – Almonty's share price is now approximately 300% higher than it was six months ago. But outstanding mining projects, good timing, and even a bit of luck are not enough to explain Almonty's unique market position: the Company has a wealth of experience and know-how that is unmatched - and in the case of tungsten, which is considered challenging to mine and process, this will continue to make the difference for many years to come.
Read
Commented by André Will-Laudien on July 2nd, 2025 | 07:25 CEST
1600% with Bitmine and Circle Internet – The next opportunities are lurking at Plug Power and naoo!
The stock market has surprises in store every day, with crypto- and AI-related business models currently causing a stir. Stocks such as Galaxy and Mara Holding are still among the harmless ones, with gains of 200 to 400%. Things really got going with Bitmine Immersion and Circle Internet. While Bitmine posted a 1,000% rally on Monday, Circle Internet took a whole month to increase its value sixfold. However, it is not necessarily the business model that determines whether stocks take off or not. Often, all it takes is a wave of discussion on the internet or social media channels and the wave breaks. Plug Power and naoo could be the next candidates for a rise. We analyze why.
Read
Commented by Armin Schulz on July 2nd, 2025 | 07:10 CEST
AI, personalized therapies, blockbusters: Evotec, NetraMark Holdings, Novo Nordisk – Your ticket to the pharmaceutical boom
As billion-dollar profits beckon and technological quantum leaps revolutionize the healthcare industry, investor excitement is surging in 2025. Investors are flocking back, attracted by unprecedented momentum. Artificial intelligence is discovering new drug candidates in record time, personalized medicine is unlocking entirely new markets, and solutions for widespread chronic diseases are driving valuations to dizzying heights. Those who understand the rules of this rapid change and identify the right partners are positioning themselves for exceptional returns. We therefore take a closer look at three compelling companies in this space: Evotec, NetraMark Holdings, and Novo Nordisk.
Read
Commented by Nico Popp on July 2nd, 2025 | 07:05 CEST
Is there a credit crunch coming? Alarm signals in the SME sector: Deutsche Bank, Commerzbank, Globex Mining
German SMEs are under pressure, struggling with the weight of the economic crisis, regulations and requirements, as well as increasingly poor financing conditions. According to Creditreform, German SMEs currently have little confidence in Germany as a business location. This mistrust is supported by a growing number of payment defaults. 11.2% of companies surveyed by Creditreform recently reported bad debt losses exceeding 1% of their turnover. Resourceful investors are already taking precautions.
Read
Commented by Armin Schulz on July 2nd, 2025 | 07:00 CEST
From microcap to market leader: How to get in on the booming billion-dollar graphene market with Argo Living Soils
Graphene sounds like something out of a science fiction novel, but it is already being used today where it matters most: in our roads and buildings. This miracle material, which is 200 times stronger than steel and as conductive as copper, is revolutionizing concrete and asphalt. It makes infrastructure more durable, drastically reduces CO₂ emissions, and lowers construction costs. For investors, this creates a perfect storm of technological advancement and sustainability pressure. Those who get in early with the companies driving this change will position themselves at the forefront of a billion-dollar market.
Read
Commented by Mario Hose on July 1st, 2025 | 09:25 CEST
Why Almonty Industries could become the BioNTech of critical metals
Between 2019 and 2021, investors in BioNTech witnessed a prime example of how a strategically relevant product – in this case, the COVID-19 vaccine – became a real stock market rocket thanks to government pressure, political support, and high public expectations. During this period, the share price rose from less than EUR 12.00 to over EUR 397.00. Those who invested early and were patient were able to achieve returns of over 3,200%. The decisive driver was not only technological innovation but also the government's determination to have the population vaccinated multiple times, which secured massive revenues for BioNTech. Today, a strikingly similar scenario is emerging with Almonty Industries (WKN: A1JSSD | ISIN: CA0203981034 | Ticker symbol: ALI) – only this time it is not about vaccines, but about the strategic raw material tungsten, which is indispensable for defense, aerospace, electronics, and mechanical engineering.
Read
Commented by André Will-Laudien on July 1st, 2025 | 07:20 CEST
Climate protection meets infrastructure: Argo Living relies on graphene for low-emission concrete
The construction industry is responsible for approximately 8% of global CO₂ emissions, and construction is taking place virtually everywhere. Anyone in the cement manufacturing industry who can significantly reduce greenhouse gas emissions is making a measurable impact on global climate targets. This creates visibility, political support, and ESG relevance, all of which are drivers for rising company valuations. The topic is highly relevant because several trillion USD will be invested in new infrastructure worldwide by 2050, including through programs such as the US Inflation Reduction Act (IRA), the EU Green Deal, and the reconstruction of Ukraine once the time comes. Investors are specifically looking for companies that are also included in these public budgets, as green building materials are considered a key technology. Argo Graphene Solutions (formerly Argo Living Soils) is perfecting this concept, and its stock is on the rise.
Read
Commented by Stefan Feulner on July 1st, 2025 | 07:10 CEST
Rheinmetall, Antimony Resources, Xiaomi – Right on trend
Although the air is getting thinner due to high valuations, especially on the US stock markets, the major indices are still striving for new highs, with the NASDAQ-100 technology exchange even climbing to another all-time high of over 22,660 points. In addition to popular defense stocks, companies involved in the production of critical metals are also trending strongly. In addition to tungsten producer Almonty Industries, another yet unknown player could soon be making a breakthrough.
Read
Commented by André Will-Laudien on July 1st, 2025 | 07:05 CEST
Innovation meets prevention: The next generation of security technologies from Volatus Aerospace
The world is in turmoil! Geopolitical conflicts, tensions between power blocs, and growing security requirements are straining public budgets and presenting governments and authorities worldwide with complex challenges. With the increasing use of digital solutions, human error must be minimized and excessive working hours reduced. This requires sophisticated technology to protect highly sensitive infrastructure such as energy, transportation, defense, and communications. As a rule, this infrastructure must be efficiently monitored and maintained for maintenance and liability reasons. In the digital age, every security-related decision is based on a foundation of data: high-resolution, up-to-date, and reliable. The regular collection and intelligent analysis of this data is essential for public institutions as well as for military applications. Volatus Aerospace (TSX-V: FLT; WKN: A2JEQU; ISIN: CA92865M1023) has its finger on the pulse!
Read
Commented by Nico Popp on July 1st, 2025 | 07:00 CEST
Disruption! Everything is changing: BioNxt Solutions, BioNTech, Bio-Rad Laboratories
The outbreak of the COVID-19 pandemic changed many things. True to the motto "just do it," companies like BioNTech have put their faith in mRNA technology—and within months, success followed, along with billions in revenue. Today, there are once again innovations with the potential to turn small companies into major cash cows. We explain what innovative healthcare companies BioNxt Solutions, BioNTech, and Bio-Rad Laboratories are currently working on and what potential this offers investors.
Read